The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Buy price moving up....now 0.17 to buy.
You're welcome Andrew......................
Was hoping for more blue days..................
Hi Kenny, thanks for the link.
Let's hope the whole is worth a lot more than the sum of the parts and the combined businesses are able to exploit the global demand for cannabis based medical and other products.
The Interim Report is due before the end of this month, so hopefully there may be further information there.
MD, Chairman and CEO of Apollon stated, "I am extremely pleased to proceed forward to complete this transaction for Sproutly to acquire Apollon's assets. I believe the combination of assets currently held by the two companies will demonstrate that the whole is more than the sum of the parts. Together these assets include multiple synergistic drug discovery technologies, pending patents and proprietary intellectual property, successful pre-clinical and clinical testing, manufacturing and production laboratories, existing exclusive global licenses and sales agreements in numerous countries which we expect to generate significant royalty revenue, and the ability to develop new combinatorial therapeutic products. I look forward to working with Dr. in building what I believe will be a leading natural biologics drug discovery company developing new therapeutic products for near term international distribution and sales".Stephen D. BarnhillArup Sen
Https://www.proactiveinvestors.com.au/LON:APOL/Apollon-Formularies-PLC/rns/1360433
Assume it will suspend soon and we get issued with new, less number of shares
Given the agreed valuation with Sproutly Canada for Apollon's assets, we should be at a valuation of circa 1.00p. A long way to go in my opinion.
Recent Share Trades for Apollon Formularies Plc (APOL.PL)
Date Time Trade Prc Volume Buy/Sell Bid Ask Value
20-Sep-23 14:09:09 0.10 100,000 Buy* 0.075 0.10 100.00 O
20-Sep-23 14:07:52 0.13 500,000 Buy* 0.075 0.10 650.00
Number 2 on
Pin to quick picksFalanx Cyber Security Limited (FCS.GB.PL) 36.00 13.50 +60.00%
Pin to quick picksApollon Formularies Plc (APOL.PL) 0.125 0.0375 +42.86%
https://www.lse.co.uk/aqse-share-prices/
Now
Need about 50 p to get anywhere near previous numbers if not higher, lost
Date Time Trade Prc Volume Buy/Sell Bid Ask Value
19-Sep-23 15:38:32 0.10 606,540 Buy* 0.05 0.10 606.54 O
19-Sep-23 10:37:18 0.13 150,776 Buy* 0.05 0.10 196.01
Up 16.67%
First time we have been blue for a very long time...
Hope so Andrew m8................
Something better than nothing, this has not been my finest hr or investment certainly
If you believe what is written in the RNS, then yes, we could yet see a positive outcome.
The buy price of the shares has moved up and on a transaction basis, the sale price represents a valuation of circa 1.00p.
We will end up being listed as Sproutly in Canada, but the shares will still be tradeable.
Life in the old dog yet Kenny.
So what does this mean? good, bad? i guess any movement is now better than nothing, whether we ever get any money, our money back not sure.
June 2021
https://apollon.org.uk/investor-relations/shareholder-information/
Https://uk.finance.yahoo.com/news/apollon-formularies-plc-execution-binding-081800801.html
Current mkt cap circa £500k
Values Apollon at £4.2m